S2Medical AB (publ) (STO:S2M)
Sweden · Delayed Price · Currency is SEK 0.0060
0.00 (0.00%)
Aug 12, 2026, 5:22 PM CET
S2Medical AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.91 | 1 | 1.52 | 3.72 | 9.48 |
Cash & Short-Term Investments | 0.91 | 1 | 1.52 | 3.72 | 9.48 |
Cash Growth | -9.73% | -33.78% | -59.25% | -60.72% | -62.56% |
Accounts Receivable | 0.69 | 2.16 | 1.44 | 1.22 | 0.75 |
Other Receivables | 0.23 | 0.17 | 0.38 | 0.41 | 0.51 |
Total Trade Receivables | 0.92 | 2.33 | 1.82 | 1.63 | 1.26 |
Inventory | 3.01 | 4.37 | 5.16 | 6.39 | 4.62 |
Other Current Assets | 0.76 | 0.78 | 0.13 | 0.19 | 0.9 |
Total Current Assets | 3.96 | 5.79 | 8.63 | 11.93 | 16.26 |
Net Property, Plant & Equipment | 0.2 | 0.43 | 0.75 | 1.19 | 1.74 |
Other Intangible Assets | 12.55 | 11.14 | 10.94 | 10.85 | 9.97 |
Goodwill | 0.19 | 0.57 | 0.95 | 1.32 | 1.7 |
Long-Term Investments | 0 | 7.42 | - | - | - |
Total Assets | 16.9 | 25.36 | 21.41 | 25.29 | 29.68 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.91 | 0.36 | 3.47 | 1.77 | 0.99 |
Accrued Expenses | 3.09 | 3.63 | 2.89 | 2.67 | 2.96 |
Current Portion of Long-Term Debt | 0 | 0 | 0 | 0 | 0.21 |
Unearned Revenue | 0.14 | 0 | 2.17 | 0.23 | 0.11 |
Other Current Liabilities | 2.89 | 2.65 | 11.22 | 13.55 | 10.73 |
Total Current Liabilities | 7.03 | 6.64 | 19.75 | 18.22 | 15 |
Total Liabilities | 7.03 | 6.64 | 19.75 | 18.22 | 15 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1.57 | 1.47 | 16.14 | 1.9 | 0.88 |
Additional Paid-in Capital | 121.49 | 120.34 | 120.18 | 104.44 | 83.55 |
Retained Earnings | -113.19 | -103.08 | -134.66 | -99.27 | -69.75 |
Shareholders' Equity | 9.87 | 18.72 | 1.66 | 7.07 | 14.68 |
Total Liabilities & Equity | 16.9 | 25.36 | 21.41 | 25.29 | 29.68 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0 | 0 | 0 | 0 | 0.21 |
Net Cash (Debt) | 0.91 | 1 | 1.52 | 3.72 | 9.27 |
Net Cash Growth | -9.73% | -33.78% | -59.25% | -59.85% | -62.14% |
Net Cash Per Share | 0.00 | 0.00 | 0.01 | 0.16 | 0.63 |
Book Value | 9.87 | 18.72 | 1.66 | 7.07 | 14.68 |
Book Value Per Share | 0.01 | 0.03 | 0.01 | 0.30 | 0.99 |
Tangible Book Value | -2.86 | 7.01 | -10.23 | -5.11 | 3.01 |
Tangible Book Value Per Share | -0.00 | 0.01 | -0.08 | -0.21 | 0.20 |